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Abstract
Background and objectives—Among HIV-positive populations, the prevalence of cigarette 
smoking remains disproportionately high and is associated with significant morbidity and 
mortality. Little is known about this topic among HIV-positive persons in the general population.
Methods—Data came from the 2005–2011 National Survey on Drug Use and Health (NSDUH) 
public use data files. Unadjusted and adjusted multinomial logistic regression analyses explored 
the associations between sociodemographic, drug and alcohol use, and drug and/or alcohol 
treatment characteristics with smoking status among HIV-positive individuals (n=349).
Results—More than 40% of the sample was current smokers. In adjusted analyses, females 
(aRRR=0.11, 95% CI=0.03–0.41) and participants who had never been married (aRRR=0.19, 95% 
CI=0.05–0.58), were morel likely to be former smokers than never smokers. Females 
(aRRR=0.37, 95% CI=0.14–0.96) and individuals older than age 35 (aRRR=0.37, 95% CI=0.16–
0.89) were less likely to be current smokers than never smokers. Conversely, previously married 
persons (aRRR=5.72, 95% CI=1.40–23.31), participants reporting binge drinking (aRRR=5.96, 
95% CI=2.27–15.64), and lifetime drug or alcohol treatment (aRRR=5.12, 95% CI=2.09–12.55) 
were more likely to be current smokers than never smokers.
Conclusions—Findings help confirm the high prevalence of smoking among HIV-positive 
persons suggesting the need for integrated substance use and smoking cessation treatment among 
HIV-positives.
Scientific significance—The present findings have implications for the development and 
implementation of targeted smoking cessation programs for HIV-positive smokers.
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Despite the declining prevalence of smoking in the United States,1 cigarette smoking is still 
highly prevalent among HIV-positive populations—three times greater than what is observed 
in the general population (approximately 50–70% versus 20%),2–7 respectively. The 
preponderance of smoking in HIV-positive populations contributes to a variety of deleterious 
health and treatment outcomes. For instance, elevated risks of chronic obstructive pulmonary 
disease (COPD),8 lung cancer,9 and cardiovascular disease8 have been observed in this 
group. In fact, lung cancer is the third most commonly diagnosed cancer among persons 
with HIV/AIDS.9 Furthermore, HIV-positive smokers lose more life-years to cigarette 
smoking than they do to HIV.10 Additionally, a study of women on highly active 
antiretroviral therapy (HAART) found that cigarette smokers had poorer viral and 
immunologic responses, greater risk of virologic rebound, more frequent immunologic 
failure, and have a higher risk of developing AIDS than non-smokers.11,12
Prior research has explored factors and characteristics associated with cigarette smoking 
among individuals with HIV in restricted samples. These include demographic factors such 
as sex,4 age,3 race/ethnicity,3 and education3,13 as well as behavioral factors like heavy 
drinking and illegal drug use.3 The latter two factors add an additional layer of complexity to 
the issue, since smoking, drug use, and HIV tend to be comorbid with one another, often 
with ill effects. Cigarette smoking among substance users is associated with adverse health 
outcomes and increased mortality,14,15 and cigarette smoking is associated with poor HIV 
treatment outcomes.12 Furthermore, untreated substance use disorders can result in poor 
HIV treatment outcomes.16 Therefore it is critical to understand associations between 
cigarette smoking and drug use in HIV-positive populations.
Though research examining the intersecting fields of smoking and HIV/AIDS has expanded 
in recent years, gaps in the literature are still evident. For instance, the majority of extant 
research has focused on clinic- or community-based samples. There has been little 
examination of smoking characteristics among HIV-positive populations at a national level. 
One notable exception is a study conducted by Collins and colleagues,2 that reported on 
changes in cigarette smoking following an HIV diagnosis among a nationally-representative 
sample of people receiving HIV care, though the analysis did not examine potential 
associations with drug use or other correlates. Additional investigation among individuals 
drawn from a nationally representative sample would contribute to the literature by 
identifying additional information and quantification regarding characteristics of HIV-
positive persons who smoke. Additionally, most investigations have focused on comparing 
current smokers versus non-smokers, without carving former smokers out from the non-
smoker category.
In light of the aforementioned gaps in the literature, the aim of the present paper is to 
describe the cigarette smoking characteristics of HIV-positive individuals drawn from a 
nationally representative sample from the US, as well as to explore the associations of the 
aforementioned characteristics with current smoking status, differentiating between current, 
former, and never smokers. We hypothesize that a majority of persons with HIV in this 
sample will be current smokers and dependent on nicotine. Additionally, we hypothesize that 
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current smokers will report greater alcohol and illegal drug use, as well as prior alcohol 
and/or drug treatment than former and never smokers, respectively. These hypothesized 
associations are significant given the negative health and treatment outcomes that may 
result: smoking11,12 and substance use17 are associated with poor medication adherence and 
HIV treatment outcomes. Combination treatment of smoking and substance use has the 
potential to improve the health and quality of life of persons living with HIV/AIDS.
Methods
Data source
Data came from the 2005 (n=55,905), 2006 (n=55,279), 2007 (n=55,435), 2008 (n=55,739), 
2009 (n=55,772), 2010 (n=57,873), and 2011 (n=58,397) National Survey on Drug Use and 
Health (NSDUH) public use data files. Consecutive years were combined to increase sample 
size of HIV-positive persons. Of the 394,400 participants surveyed, 128,144 were excluded 
because they were under the age of 18. An additional 265,900 were excluded because they 
did not self-report receiving a lifetime diagnosis of HIV. Furthermore, we excluded 7 
individuals with a lifetime HIV diagnosis who reported an “other” race/ethnicity (i.e., non-
Hispanic Native American/Alaska Native, non-Hispanic Asian, or non-Hispanic multiple 
races), due to small cell sizes and decreased power for analyses concerning these 
individuals. The remaining 349 HIV-positive individuals comprised the present analysis.
The NSDUH is sponsored by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) and is designed to provide estimates of the prevalence of extra-
medical use of legal and illegal drugs in the household population of the US, age 12 and 
older.18–24 The survey employs a 50-state design with an independent multistage area 
probability sample for each of the 50 states and the District of Columbia. To increase the 
precision of estimates, African-Americans, Hispanics, and young people were oversampled. 
Response rates for completed surveys varied between 74–76% in 2005– 2011.
Informed consent was obtained before the start of every interview. Participants were given a 
description of the study, read a statement describing the legislation that assures the 
confidentiality of any information provided by participants, and assured that participation in 
the study was voluntary. Additional information on maintenance of data confidentiality is 
available elsewhere.18–24 Surveys were administered by computer-assisted personal 
interviewing (CAPI) conducted by an interviewer and audio computer-assisted self-
interviewing (ACASI). Use of ACASI was designed to provide respondents with a private 
and confidential means of responding to questions and to increase honest reporting of illegal 
drug use and other sensitive behaviors.18–25 Respondents were offered a US $30 incentive 
payment for participation. The Johns Hopkins University Institutional Review Board 
approved this secondary data analysis.
Sampling weights for the NSDUH were computed to control for unit-level and individual-
level non-response and were adjusted to ensure consistency with population estimates 
obtained from the US Census Bureau. In order to use data from the seven years of combined 
data, a new weight was created upon aggregating the seven datasets by dividing the original 
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weight by the number of data sets combined. Further descriptions of the sampling methods 
and survey techniques for the 2005–2011 NSDUH are found elsewhere.18–24
Variables of interest
Socio-demographic Variables—Socio-demographic variables for this analysis included 
age, sex, race/ethnicity, education, total family income, and marital status. Age was 
dichotomized (18–34, 35+) and race/ethnicity was coded as a categorical variable with three 
levels: non-Hispanic White, non-Hispanic Black, and Hispanic. Educational attainment was 
dichotomized as "Less than high school" and "High school graduate or more. Total annual 
family income was categorized as follows: “<$19,000”, “$20,000–$39,000”, “$40,000–
$74,000” and “$75,000+”, and marital status was a categorical variable with three levels: 
currently married, previously married (including separated/divorced and widowed), and 
never married.
Drug and alcohol use, abuse/dependence, and treatment characteristics—
Participants were asked "How long has it been since you last [used drug/drank an alcoholic 
beverage]?" for a variety of substances, including: alcohol, painkillers, cocaine, 
hallucinogens, heroin, inhalants, marijuana, sedatives, other stimulants, and tranquilizers. 
Individuals who responded "Within the past 30 days" were labeled as past month users of 
that substance. A dichotomous (yes/no) composite variable was created that described "any 
past month drug use" that summed across each of the individual past month drug use 
variables. A dichotomous (yes/no) variable for past month alcohol use was also created in 
the same fashion as the past month drug use variables, and a dichotomous variable for 
"binge drinking", defined as drinking at least 5 drinks on the same occasion on at least 1 day 
in the past 30 days, was created as well. Lifetime drug and/or alcohol treatment was 
measured with a dichotomous (yes/no) variable. Past year abuse or dependence was 
described using dichotomous variables (yes/no) for a variety of substances (analgesics, 
cocaine, hallucinogens, heroin, inhalants, marijuana, sedatives, stimulants, tranquilizers, and 
alcohol). A composite variable was also created to describe any past year substance abuse/
dependence (not including alcohol).
Cigarette smoking characteristics—Participants were categorized as “never smokers”, 
“former smokers”, or “current smokers”. Never smokers reported smoking less than 100 
cigarettes in their lifetime. Former smokers reported smoking at least 100 cigarettes in their 
lifetime, but no cigarettes within the past 30 days. This classification scheme has been 
employed in prior research.26 Current smokers were asked a variety of additional questions 
regarding their smoking such as: the number of cigarettes smoked per day (CPD; <1, 1–5, 6–
15, 16–25, 26+), number of days smoked in the past month (1–10, 11–20, 21–30), daily 
smoking in the past month (yes/no), age at which they first tried smoking a cigarette (<10, 
11–20, 21–30, 31+), type of cigarettes smoked most often in the past 30 days (Light, Ultra 
light, Mediums, Full flavor), and whether they smoked menthol or non-menthol cigarettes. 
Current smokers also completed the Fagerström Test for Nicotine Dependence (FTND).27 
The FTND measure is defined by assessing how soon after waking a respondent had their 
first cigarette. Based on the FTND scale, a respondent was defined as having nicotine 
dependence if the first cigarette was smoked within 30 minutes of waking on the days they 
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smoked, and the respondent reported smoking cigarettes in the past month.18–24 For the 
purpose of this analysis, individuals' nicotine dependence was dichotomized (yes/no).
Statistical Analyses
Data were weighted to reflect the complex design of the NSDUH sample and were analyzed 
with STATA SE version 12.0 software.28 We used Taylor series estimation methods (STATA 
“svy” commands) to obtain proper standard error estimates for the cross-tabulations. 
Participants were stratified on the basis of smoking status (never, former, and current 
smokers), and chi-square (χ2) tests were used to determine differences in socio-
demographic, alcohol and illegal drug use, abuse/dependence, and treatment characteristics 
by smoking status. Descriptive statistics were reported to describe the cigarette smoking 
characteristics of current smokers. Unadjusted and adjusted multinomial logistic regression 
analyses were used to determine which socio-demographic, drug and alcohol use, abuse/
dependence, and treatment characteristics were associated with current cigarette smoking. 
Variables in the adjusted model included sex, age, race/ethnicity, education, income, marital 
status, past month drug use, past month alcohol use, past month binge drinking, lifetime 
drug and/or alcohol treatment, and survey year. Variables were selected based on a 




Table 1 depicts sociodemographic characteristics of the sample. The sample was 
predominantly male (82.2%), age 35+ (78.5%), and White (55.6%). Eighty percent of the 
sample reported receiving at least a high school degree, 38.2% had an annual total family 
income of $19,999 or less, and the majority (72.5%) was not married.
Significant differences between smoking statuses were found for several sociodemographic 
characteristics. In terms of sex, former smokers were least likely to report being female 
(9.0%), followed by current smokers (15.6%) and never smokers (26.7%) χ2 (2, N = 346) = 
10900, p = 0.025. Additionally, differences were found on the basis of age χ2 (6, N = 349) = 
15200, p = 0.015 and marital status χ2 (4, N = 349) = 45800, p<0.001.
Drug and alcohol use, abuse/dependence and treatment characteristics
A summary of drug and alcohol use, abuse/dependence, as well as treatment characteristics, 
can be found in Table 2. Approximately one-third (33.1%) of the sample used any illegal 
drugs within the past 30 days; the most commonly used drugs were marijuana (21.1%) and 
cocaine (7.9%). The prevalence of past month use of other drugs was comparably low 
(<6%). Past month alcohol use was common (60.6%), and past month binge drinking was 
reported by 27.2% of the sample. Twenty-seven percent of the sample reported engaging in 
alcohol or drug treatment within their lifetime. Furthermore, 13.0% of the sample met 
criteria for any substance abuse/dependence, and 13.6% met criteria for alcohol abuse/
dependence. Corresponding to measures of past month use, marijuana (5.4%) and cocaine 
(5.0%) abuse/dependence were most commonly reported.
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In terms of differences in substance use, abuse/dependence, and treatment between 
individuals of different smoking statuses, current smokers were most likely to report past 
month marijuana χ2 (2, N = 349) = 31600, p = 0.018; cocaine χ2 (2, N = 349) = 20200, p = 
0.008; or any past month substance use χ2 (2, N = 349) = 24600, p = 0.022; binge drinking 
χ2 (2, N = 349) = 55000, p<0.001; or lifetime drug/alcohol treatment χ2 (2, N = 349) = 
22200, p = 0.006. Conversely, former cigarette smokers were most likely to report past 
month use of tranquilizers χ2 (2, N = 349) = 19400, p<0.001. When examining substance 
abuse/dependence, current cigarette smokers were most likely to meet criteria for past year 
cocaine abuse/dependence χ2 (2, N = 349) = 10800, p = 0.030; or any substance abuse/
dependence χ2 (2, N = 349) = 15100, p = 0.037. Additionally, former smokers were most 
likely to report past year inhalant abuse/dependence χ2 (2, N = 349) = 10700, p = 0.026.
Cigarette smoking characteristics of current smokers
A summary of the smoking characteristics of current cigarette smokers with HIV/AIDS can 
be found in Table 3. Approximately 43% of the sample reported being current smokers. 
Smokers most commonly reported smoking between 16–25 cigarettes per day (CPD; 
32.1%), and reported smoking on 21–30 days in the past month (77.9%). More than half 
(64.5%) reported daily smoking in the past month. Eighty-three percent began smoking 
between the ages of 11–20. The most common type of cigarette smoked was Full Flavor 
(53.0%), and approximately half of the smokers (55.2%) reported smoking menthol 
cigarettes most often in the past month. According to the FTND, 63.5% of smokers met 
criteria for nicotine dependence.
Multinomial logistic regression analyses
Unadjusted and adjusted multinomial logistic regression analyses can be found in Table 4. In 
adjusted analyses, females were less likely than males (aRRR=0.11, 95% CI=0.03–0.41) and 
persons who had never been married were less likely than married persons (aRRR=0.15, 
95% CI=0.05–0.46) to be former smokers. Additionally, females (aRRR=0.37, 95% 
CI=0.14–0.96) and persons over the age of 35 (aRRR=0.37, 95% CI=0.16–0.89) were 
significantly less likely to be current smokers. Conversely, persons who reported being 
previously married (aRRR=5.72, 95% CI=1.40–23.31) were significantly more likely than 
currently married persons to be current cigarette smokers. Participants reporting binge 
drinking (aRRR=5.96, 95% CI=2.27–15.64) or lifetime drug or alcohol treatment 
(aRRR=5.12, 95% CI=2.09–12.55) were significantly more likely to be current smokers. 
Additionally, participants from survey years 2009 (aRRR=0.15, 95% CI=0.03–0.72) and 
2011 (aRRR=0.09, 95% CI=0.02–0.44) were significantly less likely than participants from 
survey year 2005 to be current smokers.
Discussion
Slightly more than 40% the sample reported current cigarette smoking; this statistic is 
roughly consistent with, though slightly lower than, the prevalence of smoking among HIV-
positive persons in prior reports (50–70%).2–4,6,7 Given that cigarette smoking among HIV-
positive persons is associated with substantial health problems, this finding is of serious 
concern.8–10 To our knowledge, this is the first study that has examined cigarette smoking 
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and drug use characteristics among HIV-positive persons, comparing never, former, and 
current smokers, drawn from a nationally representative sample.
Current, former, and never smokers in this sample of individuals with HIV were 
significantly different in terms of a number of socio-demographic characteristics. For 
instance, while less than 20% of the total sample was female, never smokers were more 
likely to report female sex than either current or former smokers. Additionally, current 
cigarette smokers were more likely to be younger than either never or former smokers. In a 
report issued by the Centers for Disease Control and Prevention, current cigarette smoking 
was more prevalent among males than females (21.6% versus 16.5%) and among younger 
individuals (25–44 years (22.1%) versus 65+ (7.9%)).29 Prior research has consistently 
shown that females utilize healthcare services more frequently than males.30,31 This 
observation may help to account, at least partially, for the sex findings in this sample. It is 
possible that the elevated number of female former smokers may be a result of increased 
contact with healthcare providers and subsequent promotion of smoking cessation during 
these visits: one study found that 81% of smokers living with HIV surveyed had received 
medical advice to quit smoking within the past year.32
Individuals living with HIV under the age of 35 were significantly more likely than older 
persons to be current smokers. Focus on smoking cessation among younger smokers is 
important. Quitting smoking prior to the age of 35 has been shown to result in life 
expectancies comparable to that of never smokers.33 Corresponding research concerning life 
expectancies following cessation has yet to be conducted among HIV-positive populations. 
However, findings from the present study, indicating that current smokers are more likely to 
be younger, have implications for continued efforts to promote smoking cessation among 
this group in an effort to maximize quality of life and life expectancies. Former smokers 
were more likely to report being married than were current or never smokers. Prior research 
has shown that entry into marriage is associated with reductions in substance use.34 Thus, it 
is possible that spouses exert a form of social control regarding health behavior.35 
Interestingly, in contrast to previous research among HIV-positive persons11 and the general 
population,36 neither education nor income was found to be associated with current smoking 
in this sample.
Numerous differences between current smokers and non-smokers were observed on the basis 
of drug and alcohol use and treatment characteristics. Consistent with prior research,37 
current smokers were more likely than former or never smokers to report any past month 
drug use. Similar patterns were observed for various individual illegal substances (e.g., 
marijuana and cocaine) in unadjusted analyses. In instances where statistical differences 
were not observed between smoking statuses on the basis of substance use or abuse/
dependence, low endorsement of use or abuse/dependence (e.g., only 4 participants reported 
past month heroin use) might be the cause, leaving analyses under-powered. Similarly, 
consistent with prior research,3 binge drinking was more likely among current smokers as 
compared to never smokers. However, differences were not observed based on past year 
alcohol use. This observation is inconsistent with prior research; as described previously, 
there is a particularly strong correlation between cigarette smoking and alcohol use.38 
Additionally, reports of engaging in some form of alcohol and/or drug treatment was most 
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prevalent among current smokers, followed by former and never smokers, respectively. In 
adjusted analyses, current smokers were significantly more likely than never smokers to 
have utilized such treatments. Within some treatment communities, major life changes 
during the early portions of the recovery process are discouraged for fear of triggering 
relapse, and the treatment culture has accepted that quitting tobacco use would constitute a 
major life change.39,40 Additionally, in some treatment organizations, smoking is a part of 
the staff culture, where staff members take smoking breaks with one another, and sometimes 
even with their clients.41 It should be noted that observed associations between smoking 
status and substance/alcohol use could be at least partially a result of residual confounding. 
A variety of characteristics, such as general health awareness or concern about one’s health, 
may help to explain these associations.
In terms of smoking characteristics, our findings are largely consistent with findings from 
previous research. A sizable portion of HIV-positive individuals in this sample reported 
current smoking, with a prevalence that is slightly lower than, but roughly consistent with 
other estimates reported.2–4 Smokers in this sample smoked approximately a pack of CPD, 
slightly more CPD than reported in other samples of HIV-positive smokers.3 The estimated 
prevalence of nicotine dependence, as judged by the FTND, in this sample is also roughly 
consistent with findings from prior studies.3,13
Findings from the present suggest a need for integrated substance abuse and cigarette 
smoking cessation treatment for HIV-positive persons, possibly linked to HIV treatment 
itself. Baca and Yahne42 have offered several suggestions for integrating smoking cessation 
therapies into substance abuse treatment, which are likely also applicable to efforts to 
integrate cessation therapy into the treatment of HIV. To begin, staff and practitioners should 
be provided with training to help patients with smoking cessation. This step is particularly 
important, since in a survey of providers listed in the HIV medicine Association, only 22.9% 
reported that they had ever received formal training or clinical education on this topic43. 
Additionally, all patients and staff who currently smoke should be provided with multiple 
opportunities for cessation and given a variety of options in terms of smoking cessation 
methodologies. Niaura and colleagues 44 have summarized findings from a variety of 
existing cessation interventions among HIV-positive smokers and found some evidence for 
their effectiveness.
Findings from this study should be interpreted in the context of several limitations. For 
instance, the cross-sectional nature of the NSDUH renders us unable to make statements 
regarding the causal nature of observed associations. Additionally, the NSDUH does not 
contain questions pertaining to treatment for nicotine dependence, or other smoking 
cessation-related information such as use of nicotine replacement therapy, which would aid 
in further characterizing this sample, as well as further our knowledge of smoking cessation 
behaviors among HIV-positive smokers. Furthermore, given that all information was 
collected via self-report, social desirability bias is a potential concern. For instance, the lack 
of biochemical validation of smoking status and substance use may result in under-reporting 
of smoking and other substance use. Additionally, it is possible that there is some amount of 
under-reporting of HIV status in this sample. As a result, this sample of HIV-positive 
smokers may be unique, and may be limited in generalizability to the US general population. 
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We are unable to determine whether this under-reporting is due to social desirability bias or 
to a lack of awareness of HIV status on the part of participants’. Additionally, some 
individuals may under-report cigarette smoking, resulting in their classification as “non-
smokers”, and also under-report other substance use. Consequently, this can result in inflated 
statistical significance of drug use among current smokers as compared to non-smokers. 
Also, because we excluded individuals of “other” race/ethnicity from these analyses due to a 
small sample size, we are limited in our abilities to examine some racial/ethnic differences.
In spite of the aforementioned limitations, the present study has several strengths as well. 
Findings from this study are in line with previous research and help to confirm that cigarette 
smoking is a significant public health issue among HIV-positive persons, both in terms of 
overall smoking prevalence, as well as the proportion of HIV-positives who smoke daily and 
are nicotine dependent. Additionally, findings from the present study enhance our 
understanding of the highly comorbid nature of cigarette smoking and drug and alcohol use 
among persons with HIV. Future research should include further examination of the nature 
of cigarette smoking among HIV-positive persons, for instance the role that HIV symptoms 
may play in cognitive smoking processes.45 Findings from such studies may help to improve 
smoking cessation treatments among HIV-positive individuals.
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Table 3
Cigarette smoking characteristics of current smokers living with HIV/AIDS age 18 and older (n=169). Data 
from the 2005–2011 National Survey on Drug Use and Health, United States.
Characteristic N Wt%a (SE)b
Cigarettes Per Day (CPD)
 <1 8 6.4 (2.93)
 1–5 51 28.9 (6.82)
 6–15 53 25.4 (4.21)
 16–25 42 32.1 (7.75)
 26+ 15 7.2 (2.47)
Days smoked in past month
 1–10 22 8.7 (2.45)
 11–20 18 13.4 (4.43)
 21–30 129 77.9 (5.03)
Daily smoking in the past month
 No 55 35.5 (6.30)
 Yes 114 64.5 (6.30)
Age first tried a cigarette
 <10 18 9.6 (3.88)
 11–20 138 83.0 (4.97)
 21–30 11 6.9 (3.28)
 31+ 1 0.5 (0.51)
Type of cigarette smoked most often in past 30 days
 Light 44 34.3 (6.02)
 Ultra Light 9 8.7 (3.46)
 Mediums 12 4.0 (1.62)
 Full Flavor 104 53.0 (7.15)
Smoke menthol cigarettes most often in past 30 days
 Non-menthol 82 55.2 (7.12)
 Menthol 87 44.8 (7.12)
Fagerström Test of Nicotine Dependence (FTND)
 No 63 36.5 (5.74)
 Yes 106 63.5 (5.74)
aWeighted percentage
bSE = standard error





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Am J Addict. Author manuscript; available in PMC 2016 May 19.
